Meridian Bioscience to Participate in H.C. Wainwright Global Life Sciences 2021 Virtual Conference March 4, 2021 Read More
Meridian Bioscience Corrects Prior Update Regarding Revogene® SARS-CoV-2 EUA Withdrawal February 23, 2021 Read More
Meridian Bioscience Provides a Further Update on the Revogene® SARS-CoV-2 EUA Submission February 23, 2021 Read More
Meridian Bioscience Provides an Update on the Revogene® SARS-CoV-2 EUA Submission February 16, 2021 Read More
Meridian Bioscience Reports Record Setting First Quarter Fiscal 2021 Operating Results and Raises Full Year Fiscal 2021 Guidance February 5, 2021 Read More
Meridian Bioscience Expands Production Capacity with Support from NIH, JobsOhio, and the Village of Newtown February 3, 2021 Read More
Meridian’s Air-Dryable Master Mixes Replace Lyophilization in the Manufacturing of Molecular Assays February 2, 2021 Read More
Meridian Bioscience to Hold First Quarter Fiscal 2021 Financial Results Conference Call on February 5, 2021 January 13, 2021 Read More
